Our journey in the Center for Advancing Innovations’ Nano Startup Challenge in Cancer has been both engaging and challenging – each member playing a crucial role and essential in creating a comprehensive business structure. As students and pharma professionals, our team has a strong foundation in many different areas of medicine and science. Our entrepreneurial experience is definitely limited, but through research and exposure to different business models, long discussions, and guidance from our mentors, we feel at this point, we have a solid, promising business plan.
We’re excited to move to the next phase of the competition! Our invention – infrared-activated liposomes – has a thrilling amount of potential, and we really can’t wait to start raising capital. As “Precision Nanotech”, we’d utilize the vast applicability of the technology as a licensed platform to improve chemotherapies for a variety of cancers. By licensing the technology, we’ll be able to quickly generate a revenue stream and avoid leveraging seed money in long, risky clinical trials.
Each of us is so happy to have the opportunity to participate in this challenge: to take a potentially groundbreaking technology invented by the NIH and make it available to millions of patients in need, to work with industry leaders, and to conceptualize and build a company from the ground up. The Center for Advancing Innovation has done an exceptional job at providing quality education and assistance for the teams, and we’ve learned so much already. We’re anticipating even greater experiences as we move forward into making this project a reality. -David Winters
We’re excited to move to the next phase of the competition! Our invention – infrared-activated liposomes – has a thrilling amount of potential, and we really can’t wait to start raising capital. As “Precision Nanotech”, we’d utilize the vast applicability of the technology as a licensed platform to improve chemotherapies for a variety of cancers. By licensing the technology, we’ll be able to quickly generate a revenue stream and avoid leveraging seed money in long, risky clinical trials.
Each of us is so happy to have the opportunity to participate in this challenge: to take a potentially groundbreaking technology invented by the NIH and make it available to millions of patients in need, to work with industry leaders, and to conceptualize and build a company from the ground up. The Center for Advancing Innovation has done an exceptional job at providing quality education and assistance for the teams, and we’ve learned so much already. We’re anticipating even greater experiences as we move forward into making this project a reality. -David Winters
RSS Feed
